BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12639166)

  • 21. Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.
    Taylor JL; Liu M; Hoff DS
    J Pediatr Pharmacol Ther; 2015; 20(2):128-37. PubMed ID: 25964730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
    Muhammad Redzwan SRA
    Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapleural Alteplase and Dornase in a Pregnant Woman With Complicated Parapneumonic Effusion.
    Amariei DE; Tran BC; Yao R; Britt EM; Holden VK; Sachdeva A; Pickering EM
    Ann Thorac Surg; 2019 Nov; 108(5):e293-e294. PubMed ID: 30978314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults.
    Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D
    Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
    Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
    Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
    Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
    Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study.
    Stefanutti G; Ghirardo V; Barbato A; Gamba P
    Surgery; 2010 Sep; 148(3):589-94. PubMed ID: 20304453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema.
    Huang HC; Chang HY; Chen CW; Lee CH; Hsiue TR
    Chest; 1999 Mar; 115(3):751-6. PubMed ID: 10084488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
    Gilbert CR; Wilshire CL; Chang SC; Gorden JA
    Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapleural tissue plasminogen activator for complicated pleural effusions.
    Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
    J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapleural streptokinase in management of parapneumonic effusions. Report of series and review of literature.
    Mitchell ME; Alberts WM; Chandler KW; Goldman AL
    J Fla Med Assoc; 1989 Dec; 76(12):1019-22. PubMed ID: 2689573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions.
    Henke CA; Leatherman JW
    Am Rev Respir Dis; 1992 Mar; 145(3):680-4. PubMed ID: 1546851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; OzyĆ¼rek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural urokinase treatment in children with complicated parapneumonic effusion.
    Chen JP; Lue KH; Liu SC; Cheng SL; Sheu JN
    Acta Paediatr Taiwan; 2006; 47(2):61-6. PubMed ID: 16927629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.
    Merlo LG; Ansari S; Singh B; Teferedgin FF; Cervellione KL; Gintautas J; Babury MA
    Proc West Pharmacol Soc; 2009; 52():11-3. PubMed ID: 22128410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrapleural Thrombolytics for Parapneumonic Effusion: A Network Metaanalysis.
    Sridharan K; Sivaramakrishnan G
    Curr Rev Clin Exp Pharmacol; 2024; 19(2):204-212. PubMed ID: 36173062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.